Avantor Inc (AVTR)
NYSE:AVTR
Want to see AVTR full AI Analyst Report?
AVTR Stock Chart & Stats
$8.52
-$0.18(-0.80%)
At close: 4:00 PM EST
$8.52
-$0.18(-0.80%)
Day’s Range― - ―
52-Week Range$7.27 - $15.93
Previous CloseN/A
Volume664.76K
Average Volume (3M)8.56M
Market Cap
$5.43B
Enterprise Value$5.19B
Total Cash (Recent Filing)$279.30M
Total Debt (Recent Filing)$37.00M
Price to Earnings (P/E)30.7
Beta0.86
Next Earnings
Jul 23, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding682,755,430
10 Day Avg. Volume8,471,297
30 Day Avg. Volume8,562,219
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit2.47
Enterprise Value/Ebitda39.61
Forecast
1Y Price Target
$9.46Price Target Upside11.01% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)0.79
Revenue Forecast (FY)$6.50B
Bulls Say, Bears Say
Bulls Say
Distribution Recovery And Brand RevivalRevival of the VWR brand combined with go-to-market and e-commerce upgrades could recapture lost market share and accelerate recovery in the distribution business.
Fiscal Guidance ConfidenceReaffirmed fiscal 2026 guidance signals management confidence in achieving strategic targets and supports expectations for steady operational progress.
Operational Reorganization And FocusReorganizing into two focused segments for distribution and bioscience, alongside targeted operational improvements, could increase transparency and enable more focused resource allocation.
Bears Say
Bioscience Segment PressuresShrinking volumes, operational bottlenecks, and difficult comparisons in the Bioscience and MedTech segment could weigh on revenue growth and pressure profitability.
Leadership UncertaintyDeparture of the chief financial officer introduces leadership uncertainty over financial strategy and may delay execution of strategic initiatives.
Margin And Cash Flow WeaknessCompressed margins and disappointing free cash flow amid weak sales growth undermine earnings visibility and increase downside risk to valuation.
Avantor News
AVTR FAQ
What was Avantor Inc’s price range in the past 12 months?
Avantor Inc lowest stock price was $7.26 and its highest was $15.93 in the past 12 months.
What is Avantor Inc’s market cap?
Avantor Inc’s market cap is $5.43B.
When is Avantor Inc’s upcoming earnings report date?
Avantor Inc’s upcoming earnings report date is Jul 23, 2026 which is in 80 days.
How were Avantor Inc’s earnings last quarter?
Avantor Inc released its earnings results on Apr 29, 2026. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.157 by $0.013.
Is Avantor Inc overvalued?
According to Wall Street analysts Avantor Inc’s price is currently Undervalued.
Does Avantor Inc pay dividends?
Avantor Inc does not currently pay dividends.
What is Avantor Inc’s EPS estimate?
Avantor Inc’s EPS estimate is 0.19.
How many shares outstanding does Avantor Inc have?
Avantor Inc has 682,755,430 shares outstanding.
What happened to Avantor Inc’s price movement after its last earnings report?
Avantor Inc reported an EPS of $0.17 in its last earnings report, beating expectations of $0.157. Following the earnings report the stock price went down -0.127%.
Which hedge fund is a major shareholder of Avantor Inc?
Currently, no hedge funds are holding shares in AVTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avantor Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.46 (11.01% Upside)
$9.46 (11.01% Upside)
Blogger Sentiment
Neutral
AVTR Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.6%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.57%
12-Months-Change
Fundamentals
Return on Equity
-9.59%
Trailing 12-Months
Asset Growth
-5.38%
Trailing 12-Months
Company Description
Avantor Inc
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
AVTR Company Deck
AVTR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: clear operational progress from the Revival program (leadership refresh, digital and kaizen-driven efficiency projects, improved BMP order trends and e-commerce gains) and a Q1 outperformance on EPS versus expectations. However, meaningful near-term revenue declines, margin pressure from mix and freight, customer prebates depressing early cash flow, geopolitical inflationary risk ($10–$20M headwind) and a CFO transition temper the outlook. Management reaffirmed guidance and expects stabilization in H1 with a path to organic growth in H2, but execution and macro risks will determine whether that recovery materializes.View all AVTR earnings summariesAVTR Net sales Breakdown
58.44% Americas
34.74% Europe
6.82% AMEA
AVTR Stock 12 Month Forecast
Average Price Target
$9.46
▲(11.01% Upside)
Technical Analysis
Albemarle
―
Eastman Chemical
―
Quaker Chemical
―
Sociedad Quimica Y Minera SA
―
Westlake Corporation
―
Ownership Overview
0.96% Insiders
41.26% Mutual Funds
4.63% Other Institutional Investors
35.22% Public Companies and
Individual Investors